Major adverse cardiovascular events

Results 61 to 70 of about 8,911,089 (208)

Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery [PDF]

JAMA Cardiology, 2017
Major adverse cardiovascular and cerebrovascular events (MACCE) are a significant source of perioperative morbidity and mortality following noncardiac surgery.To evaluate national trends in perioperative cardiovascular outcomes and mortality after major noncardiac surgery and to identify surgical subtypes associated with cardiovascular events using a ...
Nathaniel R, Smilowitz +5 more
openaire +2 more sources

Neutrophil-mediated effects of S100A12 on major adverse cardiovascular events: Insights from the UK biobank

American Journal of Preventive Cardiology
Background: S100A12, a pro-inflammatory protein primarily secreted by neutrophils, has been implicated in vascular inflammation and atherosclerosis. However, its role in major adverse cardiovascular events (MACE) remains unclear.
Qingqing Zhang +4 more
doaj +1 more source

Major adverse cardiovascular events of the patients with CAD followed-up.

, 2013
Major adverse cardiovascular events of the patients with CAD followed-up.
Naifeng Liu (311606) +5 more
core +1 more source

Metformin and major adverse cardiovascular events

, 2020
Aim The Italian Society of Diabetology and the Italian Association of Clinical Diabetologists are developing new guidelines for drug treatment of type 2 diabetes.
Matteo Monami
core +1 more source

Univariate analysis for predictors of major adverse cardiovascular events.

, 2015
ACS: acute coronary syndrome;hsCRP: high sensitivity C-reactive protein;LVEF: left ventricular ejection fraction.Univariate analysis for predictors of major adverse cardiovascular events.
Chun-Chi Chen (103097) +8 more
core +1 more source

Kaplan-Meier curves for major adverse cardiovascular events (MACE) in the younger vascular age group and older vascular age group.

, 2022
Kaplan-Meier curves for major adverse cardiovascular events (MACE) in the younger vascular age group and older vascular age group.
Satoshi Kodera (3472406) +22 more
core +1 more source

Glycemic levels and cardiovascular events in type 2 diabetes: A cohort study of drugs with different hypoglycemic potentials

Scientific Reports
Research indicates a U-shaped association between mortality and glycated hemoglobin (HbA1c) levels in patients receiving sulfonylurea or insulin. However, the relationship between glucose levels and cardiovascular events in patients on novel agents with ...
Yi-Cheng Lin +5 more
doaj +1 more source

Details of cardiovascular death, non-cardiovascular death, and other major adverse cardiovascular events.

Details of cardiovascular death, non-cardiovascular death, and other major adverse cardiovascular events.
Takashi Ogane (16542172) +4 more
core +1 more source

Rate of 30-day major adverse cardiovascular events categorised by RCRI and HFRS.

, 2022
* Historical rate of MACE (composite of death, myocardial infarction or cardiac arrest at 30-days) from the 2017 Canadian Cardiovascular Society Guidelines of Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac ...
Erik Youngson (813105) +5 more
core +1 more source

Subgroup analysis for (A) major adverse cardiovascular events (MACE), and (B) stroke.

, 2014
Subgroup analysis for (A) major adverse cardiovascular events (MACE), and (B) stroke.
El-Wui Loh (608396) +6 more
core +1 more source

major adverse limb events
mortality
medicine

diabetes
peripheral artery disease
major adverse cardiovascular event